Efficacy of Etoricoxib, Celecoxib, Lumiracoxib, Non-Selective NSAIDs, and Acetaminophen in Osteoarthritis: A Mixed Treatment Comparison

Open Rheumatology Journal - Netherlands
doi 10.2174/1874312901206010006
Full Text
Abstract

Available in full text

Categories
Rheumatology
Date
Authors
Publisher

Bentham Science Publishers Ltd.

Related search

Celecoxib in the Treatment of Osteoarthritis

Clinical Medicine Insights: Therapeutics
MedicinePharmacologyPharmaceutical Science
2010English

Efficacy of Local Nsaids Therapy With Osteoarthritis Different Localization

Medical Council
2017English

Lack of Efficacy of Acetaminophen in Treating Symptomatic Knee Osteoarthritis

Archives of Internal Medicine
2003English

The Selective COX-2 Inhibitor Etoricoxib Reduces Acute Inflammatory Markers in a Model of Neurogenic Laryngitis but Loses Its Efficacy With Prolonged Treatment

Inflammation Research
ImmunologyPharmacology
2010English

PMS71 Utilization of Duloxetine and Celecoxib in Osteoarthritis Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Efficacy of Biological Agents Administered as Monotherapy in Rheumatoid Arthritis: A Bayesian Mixed-Treatment Comparison Analysis

Therapeutics and Clinical Risk Management
2015English

All-Cause Mortality of Elderly Australian Veterans Using COX-2 Selective or Non-Selective NSAIDs: A Longitudinal Study

British Journal of Clinical Pharmacology
Pharmacology
2010English

Can Celecoxib Enhance Palmitoylethanolamide's Effect in the Treatment of Temporo-Mandibular Arthralgia in Osteoarthritis Patients?

Journal of Translational Science
2018English

Cardiovascular Safety of Lumiracoxib: A Meta-Analysis of Randomised Controlled Trials in Patients With Osteoarthritis

European Journal of Clinical Pharmacology
MedicinePharmacology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy